Transcription of profile - PhRMA
{{id}} {{{paragraph}}}
Example: dental hygienist
profile - PhRMA
ProfilePHARMACEUTICAL INDUSTRYKey FactsSee inside back cover for of Sales That Went to R&D in 20097 Domestic R&DAs a percentage of domestic sales = R&DAs a percentage of total sales = and Development (R&D) Time to develop a drug = 10 to 15 years1 Development Costs Cost to develop a drug2005 = $ billion22001 = $802 million31987 = $318 million31975 = $138 million3 Cost to develop a biologic2005 = $ billion4 Sales Generic share of market202000 = 49%2009 = 74%Approvals Drugs and biologics approved in 2009 = 349 In the 27 years since the Orphan Drug Act was established, nearly 350 orphan drugs have been Only 2 of 10 marketed drugs return revenues that match or exceed R&D of Medicines Cancer: Since 1980, life expectancy for can-cer patients has increased about 3 years, and 83% of those gains are attributable to new treatments, including Another study found that medicines specifi -cally account for 50% to 60% of increases in survival rates since Cardiovascular Disease: According to the American Heart Association (AHA), death rates for cardiovascular disease fell a dramatic between 1999 and The AHA lists better control of high blood pressure a
Letter from PhRMA’s President and CEO The past year was one of the most challenging our country has faced in quite some time. We were left shaken by an uncertain economy and all the trials that came along with it.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: